US FDA panel rejects Biogen’s ALS medication’s efficacy
A panel of U.S. Food and Drug Administration (FDA) advisers on Wednesday…
The most popular over-the-counter decongestant, phenylephrine, is being reevaluated by an FDA panel after being deemed ineffective.
The Food and Drug Administration plans to ask a panel of its…
